BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 19813257)

  • 1. Evidence-based evaluation of the risks of malignancy predicted by thyroid fine-needle aspiration biopsies.
    Marchevsky AM; Walts AE; Bose S; Gupta R; Fan X; Frishberg D; Scharre K; Zhai J
    Diagn Cytopathol; 2010 Apr; 38(4):252-9. PubMed ID: 19813257
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fine-needle aspiration of follicular patterned lesions of the thyroid: Diagnosis, management, and follow-up according to National Cancer Institute (NCI) recommendations.
    Faquin WC; Baloch ZW
    Diagn Cytopathol; 2010 Oct; 38(10):731-9. PubMed ID: 20049964
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A simplified Bethesda System for reporting thyroid cytopathology using only four categories improves intra- and inter-observer diagnostic agreement and provides non-overlapping estimates of malignancy risks.
    Walts AE; Bose S; Fan X; Frishberg D; Scharre K; de Peralta-Venturina M; Zhai J; Marchevsky AM
    Diagn Cytopathol; 2012 May; 40 Suppl 1():E62-8. PubMed ID: 21557534
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Follow-up of atypia and follicular lesions of undetermined significance in thyroid fine needle aspiration cytology.
    Dincer N; Balci S; Yazgan A; Guney G; Ersoy R; Cakir B; Guler G
    Cytopathology; 2013 Dec; 24(6):385-90. PubMed ID: 23078633
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Post-thyroid FNA testing and treatment options: a synopsis of the National Cancer Institute Thyroid Fine Needle Aspiration State of the Science Conference.
    Layfield LJ; Abrams J; Cochand-Priollet B; Evans D; Gharib H; Greenspan F; Henry M; LiVolsi V; Merino M; Michael CW; Wang H; Wells SA
    Diagn Cytopathol; 2008 Jun; 36(6):442-8. PubMed ID: 18478610
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Malignancy risk for fine-needle aspiration of thyroid lesions according to the Bethesda System for Reporting Thyroid Cytopathology.
    Jo VY; Stelow EB; Dustin SM; Hanley KZ
    Am J Clin Pathol; 2010 Sep; 134(3):450-6. PubMed ID: 20716802
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fine-needle aspiration of thyroid nodules: a study of 4703 patients with histologic and clinical correlations.
    Yang J; Schnadig V; Logrono R; Wasserman PG
    Cancer; 2007 Oct; 111(5):306-15. PubMed ID: 17680588
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Implications of the proposed thyroid fine-needle aspiration category of "follicular lesion of undetermined significance": A five-year multi-institutional analysis.
    Layfield LJ; Morton MJ; Cramer HM; Hirschowitz S
    Diagn Cytopathol; 2009 Oct; 37(10):710-4. PubMed ID: 19373907
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic terminology and morphologic criteria for cytologic diagnosis of thyroid lesions: a synopsis of the National Cancer Institute Thyroid Fine-Needle Aspiration State of the Science Conference.
    Baloch ZW; LiVolsi VA; Asa SL; Rosai J; Merino MJ; Randolph G; Vielh P; DeMay RM; Sidawy MK; Frable WJ
    Diagn Cytopathol; 2008 Jun; 36(6):425-37. PubMed ID: 18478609
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fine needle aspiration of thyroid nodules in the pediatric population: a 12-year cyto-histological correlation experience at North Shore-Long Island Jewish Health System.
    Lale SA; Morgenstern NN; Chiara S; Wasserman P
    Diagn Cytopathol; 2015 Aug; 43(8):598-604. PubMed ID: 25728981
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does Hurthle cell lesion/neoplasm predict malignancy more than follicular lesion/neoplasm on thyroid fine-needle aspiration?
    Pu RT; Yang J; Wasserman PG; Bhuiya T; Griffith KA; Michael CW
    Diagn Cytopathol; 2006 May; 34(5):330-4. PubMed ID: 16604553
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The indeterminate thyroid fine-needle aspiration: experience from an academic center using terminology similar to that proposed in the 2007 National Cancer Institute Thyroid Fine Needle Aspiration State of the Science Conference.
    Nayar R; Ivanovic M
    Cancer; 2009 Jun; 117(3):195-202. PubMed ID: 19382174
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Utilization of ancillary studies in thyroid fine needle aspirates: a synopsis of the National Cancer Institute Thyroid Fine Needle Aspiration State of the Science Conference.
    Filie AC; Asa SL; Geisinger KR; Logani S; Merino M; Nikiforov YE; Clark DP
    Diagn Cytopathol; 2008 Jun; 36(6):438-41. PubMed ID: 18478603
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thyroid follicular lesion of undetermined significance: Evaluation of the risk of malignancy using the two-tier sub-classification.
    Horne MJ; Chhieng DC; Theoharis C; Schofield K; Kowalski D; Prasad ML; Hammers L; Udelsman R; Adeniran AJ
    Diagn Cytopathol; 2012 May; 40(5):410-5. PubMed ID: 22508675
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Bethesda system for reporting thyroid cytopathology: An experience of 1,382 cases in a community practice setting with the implication for risk of neoplasm and risk of malignancy.
    Wu HH; Rose C; Elsheikh TM
    Diagn Cytopathol; 2012 May; 40(5):399-403. PubMed ID: 21681976
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical significance of distinguishing between follicular lesion and follicular neoplasm in thyroid fine-needle aspiration biopsy.
    Williams MD; Suliburk JW; Staerkel GA; Busaidy NL; Clayman GL; Evans DB; Perrier ND
    Ann Surg Oncol; 2009 Nov; 16(11):3146-53. PubMed ID: 19727961
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does routine consultation of thyroid fine-needle aspiration cytology change surgical management?
    Tan YY; Kebebew E; Reiff E; Caron NR; Ogilvie JB; Duh QY; Clark OH; Ljung BM; Miller T
    J Am Coll Surg; 2007 Jul; 205(1):8-12. PubMed ID: 17617326
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Bethesda thyroid fine-needle aspiration classification system: year 1 at an academic institution.
    Theoharis CG; Schofield KM; Hammers L; Udelsman R; Chhieng DC
    Thyroid; 2009 Nov; 19(11):1215-23. PubMed ID: 19888859
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of atypia/follicular lesion of undetermined significance and repeat fine-needle aspiration: 5 years before and after implementation of the Bethesda System.
    Sullivan PS; Hirschowitz SL; Fung PC; Apple SK
    Cancer Cytopathol; 2014 Dec; 122(12):866-72. PubMed ID: 25078420
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Experience with standardized thyroid fine-needle aspiration reporting categories: follow-up data from 529 cases with "indeterminate" or "atypical" reports.
    Nga ME; Kumarasinghe MP; Tie B; Sterrett GF; Wood B; Walsh J; Nguyen H; Whyte A; Frost FA
    Cancer Cytopathol; 2010 Dec; 118(6):423-33. PubMed ID: 20945329
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.